Will pharmacist resistance hamper law to expand access to HIV prevention meds?
Pre-exposure prophylaxis can save lives, but patients seeking the medications face numerous obstacles.
By Larry Buhl, for Capital and Main
In 2012, the U.S. Food and Drug Administration approved Truvada to prevent HIV in a regimen called pre-exposure prophylaxis, or PrEP, a potential life-saving game changer for people at risk of contracting the virus.




























